Elevated expression of PD-1 on T cells and PD-L1 on TAMs has been linked to poor prognoses and increased tumor aggressiveness, further underscoring the role of dynamic tumor–immune crosstalk in shaping disease behavior [51]. The gene discussed is PDCD1; the disease is neoplasm.